Latest Security News

Neurizon Therapeutics reported a sharp rise in half-year losses to $7.28 million but marked significant progress with its lead drug NUZ-001 entering a major ALS clinical trial and securing critical regulatory designations.

ACDC Metals has completed a comprehensive metallurgical testwork program at its Goschen Central Project, confirming the viability of its processing flowsheet and advancing the project towards feasibility and potential offtake agreements.

EV Resources Limited has responded to ASX inquiries confirming the material impact of China's molybdenum export controls and recent high-grade antimony assay results on its securities.

HiTech Group has reported a robust first half for FY2025, with net profit before tax up 14% and EBITDA rising 8%, underpinned by strong demand for ICT talent and services. The company also declared a fully franked interim dividend of 5 cents per share, signaling confidence in its growth trajectory.

Kina Securities confirms its 2024 underlying profit guidance amid a non-cash statutory profit reduction driven by deferred tax asset adjustments and a customer fraud impact.

Gibb River Diamonds has secured a crucial mining lease for its Edjudina Gold Project, unlocking access to the Neta Prospect's significant gold resources and setting the stage for imminent mining operations.

QMines Limited has raised $6 million through a strongly supported placement, positioning the company to accelerate exploration and development at its Mt Chalmers and Develin Creek copper and gold projects.

Future Metals NL has addressed an ASX price query by confirming the release of drilling results from its Eileen Bore Prospect, attributing recent trading activity to investor anticipation and compliance with disclosure rules.

Althea Group Holdings has raised $4 million through a share and loan note placement to boost its THC beverage production and infrastructure across North America, targeting rapid growth in the U.S. and Canada.

The Star Entertainment Group has received a $650 million debt refinancing proposal from Oaktree Capital Management, offering a potential boost to its liquidity but shadowed by significant conditions and uncertainty.

Winsome Resources has raised approximately A$7.8 million through a placement to advance its flagship Adina Lithium Project and extend the Renard Option to August 2025, with plans for an additional share purchase plan targeting A$2.5 million.

PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.